Tags

Type your tag names separated by a space and hit enter

Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study.
Medicine (Baltimore) 2015; 94(36):e1495M

Abstract

Antihypertensives have been linked to new-onset diabetes (NOD) and different classes of antihypertensives may alter the risk for the development of NOD; however, the effect of different antihypertensives on the development of NOD in women with hypertension and coronary artery disease (CAD) has not been well studied. The purpose of this study is to investigate the association between usage of different antihypertensive drugs and the development of NOD in female patients with hypertension and CAD.Data in this retrospective cohort study were obtained from claim forms submitted to the Taiwan Bureau of National Health Insurance in central Taiwan during the period 2006-2011. We estimated the odds ratios (OR) to approximate the relative risk of NOD development associated with antihypertensive drug use.Of the 20,108 female patients with CAD at baseline, 2288 patients developed NOD during the 6-year follow-up. Subjects treated with angiotensin-converting enzyme (ACE) inhibitors (OR, 0.92; 95% confidence interval [CI], 0.84-1.00), angiotensin receptor blockers (OR, 0.92; 95% CI, 0.82-0.99), and alpha-blockers (OR, 0.88; 95% CI, 0.79-0.98) in the adjusted analyses had greater reductions of the risk than among nonusers. Patients who took diuretics (OR, 1.10; 95% CI, 1.01-1.20), beta-blockers (OR, 1.12; 95% CI, 1.04-1.21), and calcium channel blockers (OR, 1.10; 95% CI, 1.02-1.18) were at high risk of developing NOD than nonusers. Vasodilators were not associated with risk of NOD.We conclude that women with hypertension who take ACE inhibitors, angiotensin receptor blockers, and alpha-blockers are at lower risk of NOD and that use of diuretics, beta-blockers, and calcium channel blockers was associated with a significantly increased risk of developing NOD during the 6-year follow-up.

Authors+Show Affiliations

From the Department of Family Medicine and Geriatrics, Taichung Veteran General Hospital, and School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC (Y-SL); Department of Pharmacy, China Medical University Hospital and China Medical University Beigang Hospital, Taichung and Beigang Township, Yunlin County, Taiwan, ROC (H-YC, Y-SG); Central Region Branch, Bureau of National Health Insurance, Taichung, Taiwan, ROC (L-T); and Division of Internal Cardiology, Chung Shan Medical University Hospital and Chung Shan Medical University, and Basic Science, Central Taiwan University of Science and Technology, Taichung, Taiwan, ROC (G-PJ).No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26356715

Citation

Liou, Yi-Sheng, et al. "Antihypertensive Drug Use and New-Onset Diabetes in Female Patients With Coronary Artery Disease: a Population-based Longitudinal Cohort Study." Medicine, vol. 94, no. 36, 2015, pp. e1495.
Liou YS, Chen HY, Tien L, et al. Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study. Medicine (Baltimore). 2015;94(36):e1495.
Liou, Y. S., Chen, H. Y., Tien, L., Gu, Y. S., & Jong, G. P. (2015). Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study. Medicine, 94(36), pp. e1495. doi:10.1097/MD.0000000000001495.
Liou YS, et al. Antihypertensive Drug Use and New-Onset Diabetes in Female Patients With Coronary Artery Disease: a Population-based Longitudinal Cohort Study. Medicine (Baltimore). 2015;94(36):e1495. PubMed PMID: 26356715.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study. AU - Liou,Yi-Sheng, AU - Chen,Hung-Yi, AU - Tien,Lyun, AU - Gu,Yi-Sian, AU - Jong,Gwo-Ping, PY - 2015/9/11/entrez PY - 2015/9/12/pubmed PY - 2015/12/19/medline SP - e1495 EP - e1495 JF - Medicine JO - Medicine (Baltimore) VL - 94 IS - 36 N2 - Antihypertensives have been linked to new-onset diabetes (NOD) and different classes of antihypertensives may alter the risk for the development of NOD; however, the effect of different antihypertensives on the development of NOD in women with hypertension and coronary artery disease (CAD) has not been well studied. The purpose of this study is to investigate the association between usage of different antihypertensive drugs and the development of NOD in female patients with hypertension and CAD.Data in this retrospective cohort study were obtained from claim forms submitted to the Taiwan Bureau of National Health Insurance in central Taiwan during the period 2006-2011. We estimated the odds ratios (OR) to approximate the relative risk of NOD development associated with antihypertensive drug use.Of the 20,108 female patients with CAD at baseline, 2288 patients developed NOD during the 6-year follow-up. Subjects treated with angiotensin-converting enzyme (ACE) inhibitors (OR, 0.92; 95% confidence interval [CI], 0.84-1.00), angiotensin receptor blockers (OR, 0.92; 95% CI, 0.82-0.99), and alpha-blockers (OR, 0.88; 95% CI, 0.79-0.98) in the adjusted analyses had greater reductions of the risk than among nonusers. Patients who took diuretics (OR, 1.10; 95% CI, 1.01-1.20), beta-blockers (OR, 1.12; 95% CI, 1.04-1.21), and calcium channel blockers (OR, 1.10; 95% CI, 1.02-1.18) were at high risk of developing NOD than nonusers. Vasodilators were not associated with risk of NOD.We conclude that women with hypertension who take ACE inhibitors, angiotensin receptor blockers, and alpha-blockers are at lower risk of NOD and that use of diuretics, beta-blockers, and calcium channel blockers was associated with a significantly increased risk of developing NOD during the 6-year follow-up. SN - 1536-5964 UR - https://www.unboundmedicine.com/medline/citation/26356715/Antihypertensive_Drug_Use_and_New_Onset_Diabetes_in_Female_Patients_with_Coronary_Artery_Disease:_A_Population_based_Longitudinal_Cohort_Study_ L2 - http://dx.doi.org/10.1097/MD.0000000000001495 DB - PRIME DP - Unbound Medicine ER -